Genomes for kids: the scope of pathogenic mutations in pediatric cancer revealed by comprehensive DNA and RNA sequencing
S Newman, J Nakitandwe, CA Kesserwan, EM Azzato… - Cancer discovery, 2021 - AACR
Genomic studies of pediatric cancer have primarily focused on specific tumor types or high-
risk disease. Here, we used a three-platform sequencing approach, including whole …
risk disease. Here, we used a three-platform sequencing approach, including whole …
Aldehyde-Associated Mutagenesis─ Current State of Knowledge
S Vijayraghavan, N Saini - Chemical Research in Toxicology, 2023 - ACS Publications
Aldehydes are widespread in the environment, with multiple sources such as food and
beverages, industrial effluents, cigarette smoke, and additives. The toxic effects of exposure …
beverages, industrial effluents, cigarette smoke, and additives. The toxic effects of exposure …
Comprehensive genomic profiling of neuroendocrine carcinomas of the gastrointestinal system
S Yachida, Y Totoki, M Noë, Y Nakatani, M Horie… - Cancer discovery, 2022 - AACR
The neuroendocrine carcinoma of the gastrointestinal system (GIS-NEC) is a rare but highly
malignant neoplasm. We analyzed 115 cases using whole-genome/exome sequencing …
malignant neoplasm. We analyzed 115 cases using whole-genome/exome sequencing …
Genomic landscape and clinical utility in Korean advanced pan-cancer patients from prospective clinical sequencing: K-MASTER program
KH Park, JY Choi, AR Lim, JW Kim, YJ Choi, S Lee… - Cancer Discovery, 2022 - AACR
The fundamental principle of precision oncology is centralized on the identification of
therapeutically exploitable targets that provides individual patients with cancer an …
therapeutically exploitable targets that provides individual patients with cancer an …
Early tumor–immune microenvironmental remodeling and response to first-line fluoropyrimidine and platinum chemotherapy in advanced gastric cancer
Chemotherapy is ubiquitous in first-line treatment of advanced gastric cancer, yet responses
are heterogeneous, and little is known about mediators of chemotherapy response. To move …
are heterogeneous, and little is known about mediators of chemotherapy response. To move …
Sex-Biased ZRSR2 Mutations in Myeloid Malignancies Impair Plasmacytoid Dendritic Cell Activation and Apoptosis
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive leukemia of
plasmacytoid dendritic cells (pDC). BPDCN occurs at least three times more frequently in …
plasmacytoid dendritic cells (pDC). BPDCN occurs at least three times more frequently in …
Loss of TGFβ signaling increases alternative end-joining DNA repair that sensitizes to genotoxic therapies across cancer types
Among the pleotropic roles of transforming growth factor–β (TGFβ) signaling in cancer, its
impact on genomic stability is least understood. Inhibition of TGFβ signaling increases use of …
impact on genomic stability is least understood. Inhibition of TGFβ signaling increases use of …
[HTML][HTML] Structure-guided inhibition of the cancer DNA-mutating enzyme APOBEC3A
The normally antiviral enzyme APOBEC3A is an endogenous mutagen in human cancer. Its
single-stranded DNA C-to-U editing activity results in multiple mutagenic outcomes including …
single-stranded DNA C-to-U editing activity results in multiple mutagenic outcomes including …
DNA damage and oxidative stress of tobacco smoke condensate in human bladder epithelial cells
M Bellamri, SJ Walmsley, C Brown… - Chemical research in …, 2022 - ACS Publications
Smoking is a major risk factor for bladder cancer (BC), with up to 50% of BC cases being
attributed to smoking. There are 70 known carcinogens in tobacco smoke; however, the …
attributed to smoking. There are 70 known carcinogens in tobacco smoke; however, the …
[HTML][HTML] Impact of cancer evolution on immune surveillance and checkpoint inhibitor response
Intratumour heterogeneity (ITH) is pervasive across all cancers studied and may provide the
evolving tumour multiple routes to escape immune surveillance. Immune checkpoint …
evolving tumour multiple routes to escape immune surveillance. Immune checkpoint …